Y Combinator’s biotech startups incubate a new generation of therapies and tools
TechCrunch
MARCH 24, 2021
Medical and biotech had a strong showing at Y Combinator’s latest demo day , with nearly a dozen companies in the space catching my eye. Atom’s founders have published the details of their techniques in Nature Chemistry, and says it’s working on a COVID-19 test as well as therapies for the virus and other conditions.
Let's personalize your content